Tesamorelin / Ipamorelin (TESA / IPA) Blend is a research peptide combination consisting of tesamorelin, a synthetic growth hormone–releasing hormone (GHRH) analog, and ipamorelin, a selective growth hormone secretagogue receptor (GHS-R) agonist. This blend is widely studied in research settings for its coordinated activity on growth hormone signaling pathways.
In experimental models, tesamorelin stimulates pituitary growth hormone release via GHRH receptor activation, while ipamorelin acts through ghrelin receptor pathways with high selectivity and minimal off-target receptor interaction. Together, this combination is used to investigate synergistic effects on pulsatile growth hormone secretion, downstream IGF-1 signaling, and neuroendocrine regulation.
This high-purity lyophilized peptide blend provides a stable and consistent reagent for in vitro and in vivo studies examining growth hormone axis modulation and peptide–receptor interactions.
Tesamorelin / Ipamorelin (TESA / IPA) Blend is a research peptide combination consisting of tesamorelin, a synthetic growth hormone–releasing hormone (GHRH) analog, and ipamorelin, a selective growth hormone secretagogue receptor (GHS-R) agonist. This blend is widely studied in research settings for its coordinated activity on growth hormone signaling pathways.
In experimental models, tesamorelin stimulates pituitary growth hormone release via GHRH receptor activation, while ipamorelin acts through ghrelin receptor pathways with high selectivity and minimal off-target receptor interaction. Together, this combination is used to investigate synergistic effects on pulsatile growth hormone secretion, downstream IGF-1 signaling, and neuroendocrine regulation.
This high-purity lyophilized peptide blend provides a stable and consistent reagent for in vitro and in vivo studies examining growth hormone axis modulation and peptide–receptor interactions.